FDA
-
-
-
-
-
-
-
Harrow to acquire Tyrvaya nasal spray for dry eye in $100M deal
-
-
-
-
-
-
-
Harrow launches BYOOVIZ biosimilar for retinal diseases in U.S.
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Harrow Health (HROW)
-
-
-
-
-
-
-
OSRX Confirms Ongoing Licensing and Availability of Compounded Ophthalmic Medications in California
-
-
-
-
-
-
-
Harrow to Acquire Melt Pharmaceuticals
-
-
-
-
-
-
-
Harrow Health (HROW) Acquires U.S. Commercial Rights to BYQLOVI
-
-
-
-
-
-
-
Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
-
334,273 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


